Upstream Bio, Inc. (UPB)

Upstream Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	47.34	25.83	17.05
Short-Term Investments	188.47	83.98	-
Cash & Short-Term Investments	235.8	109.81	17.05
Cash Growth	-	544.01%	-
Accounts Receivable	0.51	0.1	0.41
Other Receivables	0.4	0.14	-
Receivables	0.91	0.24	0.41
Prepaid Expenses	0.06	0.12	0.09
Other Current Assets	6.26	6.83	0.75
Total Current Assets	243.03	117	18.31
Property, Plant & Equipment	0.13	0.2	0.16
Other Long-Term Assets	-	-	0.01
Total Assets	244.51	117.2	18.48
Accounts Payable	5.56	1.99	0.71
Accrued Expenses	3.95	4.48	4.06
Current Portion of Leases	-	0.05	0.09
Total Current Liabilities	10.24	6.52	4.86
Long-Term Leases	-	-	0.01
Other Long-Term Liabilities	-	2.87	6.95
Total Liabilities	10.24	9.39	11.81
Common Stock	0	0	0
Additional Paid-In Capital	6.99	4.82	1.28
Retained Earnings	-153.55	-127.97	-107.44
Comprensive Income & Other	-0.06	0.02	-
Total Common Equity	-146.61	-123.13	-106.16
Shareholders' Equity	234.27	107.81	6.67
Total Liabilities & Equity	244.51	117.2	18.48
Total Debt	-	0.05	0.09
Net Cash (Debt)	235.8	109.77	16.96
Net Cash Growth	-	547.31%	-
Net Cash Per Share	82.84	38.98	6.06
Filing Date Shares Outstanding	2.88	2.85	2.8
Total Common Shares Outstanding	2.88	2.85	2.8
Working Capital	232.79	110.48	13.45
Book Value Per Share	-50.91	-43.16	-37.91
Tangible Book Value	-146.61	-123.13	-106.16
Tangible Book Value Per Share	-50.91	-43.16	-37.91
Machinery	0.2	0.2	0.02
Construction In Progress	-	-	0.04
Leasehold Improvements	0.03	0.03	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.